158 related articles for article (PubMed ID: 26835492)
1. Imaging texture analysis for automated prediction of lung cancer recurrence after stereotactic radiotherapy.
Mattonen SA; Tetar S; Palma DA; Louie AV; Senan S; Ward AD
J Med Imaging (Bellingham); 2015 Oct; 2(4):041010. PubMed ID: 26835492
[TBL] [Abstract][Full Text] [Related]
2. Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer.
Mattonen SA; Palma DA; Haasbeek CJ; Senan S; Ward AD
Med Phys; 2014 Mar; 41(3):033502. PubMed ID: 24593744
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes.
Mattonen SA; Palma DA; Haasbeek CJ; Senan S; Ward AD
Acta Oncol; 2013 Jun; 52(5):910-8. PubMed ID: 23106174
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing recurrence from radiation-induced lung injury at the time of RECIST progressive disease on post-SABR CT scans using radiomics.
Dammak S; Gulstene S; Palma DA; Mattonen SA; Senan S; Ward AD
Sci Rep; 2024 Feb; 14(1):3758. PubMed ID: 38355768
[TBL] [Abstract][Full Text] [Related]
5. The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
Starkov P; Aguilera TA; Golden DI; Shultz DB; Trakul N; Maxim PG; Le QT; Loo BW; Diehn M; Depeursinge A; Rubin DL
Br J Radiol; 2019 Feb; 92(1094):20180228. PubMed ID: 30457885
[TBL] [Abstract][Full Text] [Related]
6. Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
Mattonen SA; Palma DA; Johnson C; Louie AV; Landis M; Rodrigues G; Chan I; Etemad-Rezai R; Yeung TP; Senan S; Ward AD
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1121-8. PubMed ID: 26907916
[TBL] [Abstract][Full Text] [Related]
7. Predicting adenocarcinoma recurrence using computational texture models of nodule components in lung CT.
Depeursinge A; Yanagawa M; Leung AN; Rubin DL
Med Phys; 2015 Apr; 42(4):2054-63. PubMed ID: 25832095
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
Nakajima N; Sugawara Y; Kataoka M; Hamamoto Y; Ochi T; Sakai S; Takahashi T; Kajihara M; Teramoto N; Yamashita M; Mochizuki T
Ann Nucl Med; 2013 Apr; 27(3):261-70. PubMed ID: 23299492
[TBL] [Abstract][Full Text] [Related]
9. High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer.
Huang K; Senthi S; Palma DA; Spoelstra FO; Warner A; Slotman BJ; Senan S
Radiother Oncol; 2013 Oct; 109(1):51-7. PubMed ID: 23953413
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of chest CT-scans following lung stereotactic ablative radiotherapy: Challenges and new insights.
De Bruycker A; Schneiders F; Gulstene S; Moghanaki D; Louie A; Palma D; Senan S
Lung Cancer; 2024 Jun; 193():107848. PubMed ID: 38908164
[TBL] [Abstract][Full Text] [Related]
11. Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer.
Yamamoto T; Kadoya N; Morishita Y; Sato Y; Matsushita H; Umezawa R; Ishikawa Y; Takahashi N; Katagiri Y; Takeda K; Jingu K
PLoS One; 2018; 13(10):e0204734. PubMed ID: 30286105
[TBL] [Abstract][Full Text] [Related]
12. Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature.
Huang K; Dahele M; Senan S; Guckenberger M; Rodrigues GB; Ward A; Boldt RG; Palma DA
Radiother Oncol; 2012 Mar; 102(3):335-42. PubMed ID: 22305958
[TBL] [Abstract][Full Text] [Related]
13. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
[TBL] [Abstract][Full Text] [Related]
14. Radiomics-based Assessment of Radiation-induced Lung Injury After Stereotactic Body Radiotherapy.
Moran A; Daly ME; Yip SSF; Yamamoto T
Clin Lung Cancer; 2017 Nov; 18(6):e425-e431. PubMed ID: 28623121
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Anal Cancer Recurrence After Chemoradiotherapy Using Quantitative Image Features Extracted From Serial
Wang J; Zhang H; Chuong M; Latifi K; Tan S; Choi W; Hoffe S; Shridhar R; Lu W
Front Oncol; 2019; 9():934. PubMed ID: 31612104
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary adenocarcinoma appearing as ground-glass opacity nodules identified using non-enhanced and contrast-enhanced CT texture analysis: A retrospective analysis.
Ye J; Ling J; Lv Y; Chen J; Cai J; Chen M
Exp Ther Med; 2020 Apr; 19(4):2483-2490. PubMed ID: 32256725
[TBL] [Abstract][Full Text] [Related]
17. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.
Senthi S; Lagerwaard FJ; Haasbeek CJ; Slotman BJ; Senan S
Lancet Oncol; 2012 Aug; 13(8):802-9. PubMed ID: 22727222
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F
BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035
[TBL] [Abstract][Full Text] [Related]
19. An automatic method for ground glass opacity nodule detection and segmentation from CT studies.
Zhou J; Chang S; Metaxas DN; Zhao B; Ginsberg MS; Schwartz LH
Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():3062-5. PubMed ID: 17946543
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of functionally weighted dose-volume parameters for thoracic stereotactic ablative radiotherapy (SABR) using CT ventilation.
Kanai T; Kadoya N; Nakajima Y; Miyasaka Y; Ieko Y; Kajikawa T; Ito K; Yamamoto T; Dobashi S; Takeda K; Nemoto K; Jingu K
Phys Med; 2018 May; 49():47-51. PubMed ID: 29866342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
